FDA Approves Therapy To Treat Gaucher Disease
WWW.MEDICALNEWSTODAY.COM - The U.S. Food and Drug Administration has approved velaglucerase alfa for injection (VPRIV) to treat children and adults with a form of the rare genetic disorder Gaucher disease. Gaucher disease occurs in people who do not produce enough of an enzyme called glucocerebrosidase. Without this enzyme, harmful amounts of a certain fatty substance (lipid) can build up in the liver, spleen, bones,…
First tweeted by healthytweet.
From the Front Page
- Comments
- Tweets (20)
Tweets
Sorry there have been no tweets in the last 7 days.
